Last reviewed · How we verify
Methyl-P plus Nutrient Formula
At a glance
| Generic name | Methyl-P plus Nutrient Formula |
|---|---|
| Also known as | Ritalin |
| Sponsor | K-PAX Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Methylphenidate Plus GWI-Nutrient Formula as a Treatment for Patients With Gulf War Illness (PHASE2)
- The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Methyl-P plus Nutrient Formula CI brief — competitive landscape report
- Methyl-P plus Nutrient Formula updates RSS · CI watch RSS
- K-PAX Pharmaceuticals, Inc. portfolio CI